logo
Plus   Neg
Share
Email

Stock Alert: AnPac Bio-Medical Science Jumps 83%

Shares of AnPac Bio-Medical Science Co., Ltd. (ANPC), a biotechnology company, are surging almost 83 percent or $3.49 in Monday's morning trade at $7.71.

Monday, AnPac Bio-Medical Science said it has made significant progress in detecting pre-cancer diseases. The company recently completed a prospective large population screening of over 110,000 individuals using its Cancer Differentiation Analysis (CDA) technology. The follow-up study involved over 13,000 individuals assessed with high cancer risk, medium cancer risk and low cancer risk using the CDA technology.

Initial results indicated that AnPac Bio's CDA technology is capable of providing meaningful information while also screening out pre-cancer diseases. Over 20 types of pre-cancer diseases were diagnosed following initial screening utilizing CDA technology and subsequent confirmation by hospital or physical testing center health check-ups.

AnPac Bio-Medical has traded in a range of $3.15 to $12.00 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Editors Pick
The United Kingdom's Competition and Markets Authority (CMA) has launched an investigation into technology giant Apple Inc. (AAPL) following complaints that its terms and conditions for app developers are unfair and anti-competitive. iPhone maker Apple also operates the App Store, which is the only... Supermarket chain Kroger Co. on Thursday reported that it posted a loss for the fourth quarter compared to a profit last year, hurt by pension plan withdrawal liabilities. Adjusted earnings per share topped analysts' estimates, while quarterly revenues missed it. However, the company initiated adjusted earning guidance for the full-year 2021, well above analysts' estimates. Retail sales are projected to grow at a potentially record rate during 2021, but the ongoing COVID-19 pandemic remains the biggest challenge for the year, according to the National Retail Federation. "There is no doubt the economy is positioned for growth in 2021, but how much growth comes down to a single non-economic force - the coronavirus," NRF Chief Economist Jack Kleinhenz said.
RELATED NEWS
Follow RTT